Kezar Life Sciences(KZR.US)

Last Updated 19:00:00 ET
longbridge loading

Kezar Life Sciences’ Risk Disclosures Rely on Cross-References, Potentially Obscuring Full Risk Picture for Investors

Tip Ranks·
US
KZR
0.00%
US
SBIO
+3.64%
US
BBH
+0.52%
Tip Ranks·
US
KZR
0.00%
US
SBIO
+3.64%
US
BBH
+0.52%

Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences

Tip Ranks·
US
AUPH
+1.29%
US
KZR
0.00%
US
SBIO
+3.64%
Tip Ranks·
US
AUPH
+1.29%
US
KZR
0.00%
US
SBIO
+3.64%

Kevin Tang named CEO of Kezar Life Sciences as multiple directors and officers resign

TradingView·
US
KZR
0.00%
TradingView·
US
KZR
0.00%

Kezar Life Sciences Announced Transfer or Voluntary Withdrawal of Listing

TradingView·
US
KZR
0.00%
US
XBI
+3.86%
US
VHT
+0.01%
TradingView·
US
KZR
0.00%
US
XBI
+3.86%
US
VHT
+0.01%

Kezar Life Sciences, Inc. (NASDAQ:KZR) Given Consensus Recommendation of "Reduce" by Analysts

Market Beat·
US
KZR
0.00%
US
ARKG
+4.52%
US
FBT
+1.54%
Market Beat·
US
KZR
0.00%
US
ARKG
+4.52%
US
FBT
+1.54%

16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?

prnewswire·
US
ULY
0.00%
US
EQH
+3.24%
US
CRBG
+3.33%
prnewswire·
US
ULY
0.00%
US
EQH
+3.24%
US
CRBG
+3.33%

13:34 ETAre APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?

prnewswire·
US
FBT
+1.54%
US
IHE
+0.34%
US
VHT
+0.01%
prnewswire·
US
FBT
+1.54%
US
IHE
+0.34%
US
VHT
+0.01%

14:15 ETSHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS

prnewswire·
US
IBB
+1.99%
US
ARKG
+4.52%
US
CNTA
+0.10%
prnewswire·
US
IBB
+1.99%
US
ARKG
+4.52%
US
CNTA
+0.10%
© 2026 Longbridge｜Disclaimer